Beta
357764

Association of Vitamin D and Antioxidant Minerals with Interferon -λ1 (Interleukin‌-29) level in Type 2 Diabetic Patients

Article

Last updated: 23 Dec 2024

Subjects

-

Tags

Pharmacology & Toxicology

Abstract

diabetes mellitus type 2 [T2DM] is associated with heightened inflammatory activity. The significance of inflammatory markers in the context of T2DM remains a subject of debate. Interferon-λ1 (IFN-λ1), also referred to as interleukin-29 [IL-29], represents a recent addition to the interferon family type III. Primarily secreted by macrophages and developing dendritic cells. IL- 29 has a crucial function in various immune reactions. Minerals and vitamins have important roles in antioxidation and anti-inflammation processes. The main aims of presented research were to assess vitamin D, antioxidant minerals (copper and zinc), and interleukin-29 in T2DM; also, to assess the diagnostic values and correlations of IL-29 with other parameters. A case-control study encompassed 30 type 2 diabetes patients (comprising 17 males and 13 females) who visited Al-Merjan Teaching Hospital in Babel, Iraq. Furthermore, a control group was established, consisting of 30 volunteers who were apparently in good health. Standard procedures and methodologies were employed to ascertain the levels of the parameters. There were significantly increases (P value < 0.05) in concentrations of IL- 29, fasting blood glucose, Hb A1c, triglyceride, total cholesterol, LDL-cholesterol and in T2DM patients. Meanwhile, there were significant decreases in zinc and vitamin D concentrations in patients in comparison with control. The most valuable receiver operator characteristic (ROC) was for FBG (0.987), Hb A1c (0.988) and IL–29 (1.0). Serum IL-29 level showed strong positive correlations with FBG and Hb A1c; on the other hand, it showed negative correlations with zinc and vitamin D (p- value < 0.05). The study found that there were increases in IL-29 levels and decreases in vitamin D, copper and zinc levels among T2DM patients. These changes are potentially the reason to develop diabetes and provide new biomarkers for detecting or assessing diabetes status.

DOI

10.21608/ejvs.2024.278774.1959

Keywords

Interferon -λ1, interleukin- 29, Vitamin D, Type 2 diabetes mellitus

Authors

First Name

Rawaa

Last Name

Adday Ali

MiddleName

-

Affiliation

Microbiology Department, College of Veterinary Medicine, Al-Qasim Green University ,Babylon 51013,Iraq.

Email

rawaaaddy33@gmail.com

City

najaf

Orcid

-

First Name

Entissar Abdul latif

Last Name

Abdul Reda

MiddleName

-

Affiliation

Medical College, University of Basra, Basra, Iraq.

Email

entissaabdul222@yahoo.com

City

najaf

Orcid

-

First Name

Hamid Jaddoa

Last Name

Abbas

MiddleName

-

Affiliation

3Al-Faiha'a Teaching Hospital, Al- Zehra 'a Medical College, University of Basra, Basra, Iraq

Email

hamidjadda3@yahoo.com

City

najaf

Orcid

-

First Name

Hanaa

Last Name

Addai Ali

MiddleName

-

Affiliation

Department of Chemistry, College of Science, University of kufa, Nagaf, Iraq

Email

hanaaaddai2@yahoo.com

City

-

Orcid

-

First Name

Naser

Last Name

Ali Naser

MiddleName

-

Affiliation

5Al-Faiha'a Teaching Hospital, Basra, Iraq.

Email

naseralinaser@yahoo.com

City

najaf

Orcid

-

First Name

mohauman

Last Name

majeed

MiddleName

mohaummed

Affiliation

kufa

Email

muhaimin.alrufaie@uokufa.edu.iq

City

najaf

Orcid

-

Volume

56

Article Issue

5

Related Issue

48063

Issue Date

2025-05-01

Receive Date

2024-03-29

Publish Date

2025-05-01

Page Start

1,075

Page End

1,080

Print ISSN

1110-0222

Online ISSN

2357-089X

Link

https://ejvs.journals.ekb.eg/article_357764.html

Detail API

https://ejvs.journals.ekb.eg/service?article_code=357764

Order

357,764

Type

Original Article

Type Code

140

Publication Type

Journal

Publication Title

Egyptian Journal of Veterinary Sciences

Publication Link

https://ejvs.journals.ekb.eg/

MainTitle

Association of Vitamin D and Antioxidant Minerals with Interferon -λ1 (Interleukin‌-29) level in Type 2 Diabetic Patients

Details

Type

Article

Created At

23 Dec 2024